Skip to main content

Table 3 Sociodemographic and behavioural characteristics of women interviewed

From: Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study

Characteristic

No Intervention Group (NIG)

Intervention groups

Total

P

Letter (IG1)

Letter + leaflet (IG2)

Letter + leaflet + phone call (IG3)

Interviewed

857

807

848

1011

3523

 

Age, mean (SD)

50.8 (12.7)

49.5 (12.1)

50.0 (12.4)

51.1 (12.0)

50.4 (12.3)

0.018

Spanish nationality

827 (96.5%)

744 (92.2%)

768 (90.7%)

900 (89.1%)

3239 (92.0)

<0.001

Educational level

 None

43 (5.1%)

82 (11.9%)

64 (9.5%)

71 (8.0%)

260 (8.4%)

<0.001

 Primary

504 (30.1%)

380 (27.5%)

377(28.0%)

423 (23.8%)

1684 (27.2%)

 

High School/ University

291(17.3%)

229(16.5%)

231(17.2%)

395(22.2%)

1146(18.5%)

 

Marital status-married

594 (70.3%)

518 (74.6%)

513 (76.5%)

666 (74.7)

2291 (73.9%)

0.037

Number of children

 0

93 (11.0%)

97 (14.0%)

74 (11.0%)

114 (12.8%)

379 (12.2%)

0.002

 1-2

443 (52.5%)

404 (58.4%)

394 (58.5%)

524 (58.9%)

1765 (57.0%)

 

  > 2

308 (36.5%)

191 (27.6%)

205 (30.5%)

251 (28.2%)

955 (30.8%)

 

Lag time since last Pap screening

 1-3 years

417 (48.7%)

348 (43.8%)

369 (44.6%)

421 (42.1%)

1555 (44.7%)

0.002

 4-6 years

322 (37.6%)

282 (35.5%)

294 (35.6%)

391 (39.1%)

1289 (37.1%)

 

 never

117 (13.7%)

164 (20.7%)

164 (19.8%)

189 (18.9%)

634 (18.2%)

 

Reasons for non-attendance to screening for women with no previous Pap

 Fear and dislike

23 (19.8%)

65 (41.1%)

68 (42.2%)

73 (40.3%)

229 (37.2%)

<0.001

 Uninformed

91 (78.4%)

84 (53.2%)

80 (49.7%)

98 (54.1%)

353 (57.3%)

 

 Other

2 (1.7%)

9 (5.7%)

13 (8.1%)

10 (5.5%)

34 (5.5%)

 
  1. The questionnaires completed for the intervention groups were carried out during routine medical visits. For the non-intervention group the questionnaires were completed at the end of the study by appropriately trained personnel during a telephone call
  2. Source: (Acera et al.: Increasing cervical cancer screening coverage: a randomised, community-based clinical trial, accepted and forthcoming)